One more week! NIH Office of AIDS Research Survey: Due by March 28, 2024

Your input matters! Help shape the future of HIV research priorities by filling out the NIH Office of AIDS Research survey before the deadline on March 28th, 2024. Share your feedback today to inform the development of the FY 2026‒2030 NIH Strategic Plan for HIV and HIV-Related Research.

From the Office of AIDS Research:

Purpose

Through this Request for Information (RFI), the Office of AIDS Research (OAR) in the Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI), National Institutes of Health (NIH), invites feedback from researchers, health care professionals, advocates and health advocacy organizations, scientific or professional organizations, federal/state/local government agencies, community, and other interested constituents on the development of the fiscal year (FY) 2026-2030 NIH Strategic Plan for HIV and HIV-Related Research (the Plan). The Plan guides the NIH investment, building on scientific progress and opportunities for advancing HIV/AIDS research toward an end to the pandemic.

Background

The most recent statistics from the Joint United Nations Programme on HIV/AIDS estimate that worldwide in 2022, 39 million people were living with HIV, 1.3 million people acquired HIV, and 630,000 people died from AIDS-related illnesses. The Centers for Disease Control and Prevention estimates that in the United States in 2021, 1.2 million people were living with HIV, with disparities by age, race, gender, and ethnicity. There were over 36,000 new HIV diagnoses documented in the U.S. in 2021, and an estimated 66% of people with diagnosed HIV achieved viral suppression. These statistics point to the need for expanded access and choice among current HIV prevention, testing, and treatment methods, as well as the need for an effective HIV vaccine and a scalable HIV cure. Global patterns of HIV epidemiology underscore the necessity for research and implementation strategies to address the intersectional nature of health disparities, including social determinants of health.  

NIH OAR oversees and coordinates all HIV research activities across NIH, including both extramural and intramural research, research training, program evaluation, and HIV research infrastructure and capacity development. NIH supports a comprehensive portfolio of research representing a broad range of basic, clinical, behavioral, social, translational, and implementation science on HIV and associated coinfections and comorbidities. The Plan provides a framework for developing the NIH HIV research budget, articulates HIV research priorities, and provides information about NIH HIV research priorities to the scientific community, Congress, HIV-affected communities, and the public at large. 

Since 2015, the NIH HIV research portfolio has been framed according to five overarching priority areas: 1) Reduce the incidence of HIV; 2) Develop next-generation HIV therapies; 3) Conduct research toward HIV cure; 4) Address HIV-associated comorbidities, coinfections, and complications; and 5) Advance cross-cutting areas of research (including basic research, behavioral and social sciences research, health disparities, trainings, capacity-building and infrastructure). To capitalize on advances in HIV science that span multiple areas (e.g., the use of long-acting injectable ART for both prevention and treatment) and to promote a multidisciplinary and integrative approach, OAR proposes a new framework based on the HIV research-to-practice continuum for priority setting.

To read more and fill out the survey:

CLICK HERE

Please direct all inquiries to: